Provided by Tiger Fintech (Singapore) Pte. Ltd.

ARS PHARMACEUTICALS INC

12.49
-0.1400-1.11%
Post-market: 12.490.00000.00%17:03 EDT
Volume:1.19M
Turnover:14.83M
Market Cap:1.23B
PE:156.13
High:12.78
Open:12.63
Low:12.21
Close:12.63
Loading ...

ARS Pharmaceuticals (SPRY) Receives a Buy from William Blair

TIPRANKS
·
03 Mar

ARS Pharmaceuticals Inc : >:  Oppenheimer Initiates Coverage With Outperform Rating and Target Price $40

THOMSON REUTERS
·
10 Feb

Oppenheimer Initiates ARS Pharmaceuticals at Outperform

MT Newswires Live
·
10 Feb

VR Resources Provides Exploration Update on Silverback and Empire Projects in Ontario

MT Newswires
·
06 Feb

ARS Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Conference

GlobeNewswire
·
05 Feb

BRIEF-Ars Pharmaceuticals Inc Files For Mixed Shelf Size Not Disclosed - SEC Filing

Reuters
·
01 Feb

ARS Pharmaceuticals files automatic mixed securities shelf

TIPRANKS
·
01 Feb

ARS Pharmaceuticals Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
01 Feb

3 US Growth Stocks With Significant Insider Ownership

Simply Wall St.
·
31 Jan

VR Resources Says Drilling Underway At Silverback Copper-Gold Project

MT Newswires
·
29 Jan

ARS Pharmaceuticals on Track for Record Winning Streak -- Data Talk

Dow Jones
·
28 Jan

ARS Pharmaceuticals Launches neffyinSchools Program Providing Free Life-Saving Needle-Free Epinephrine For Emergency Use to Eligible K-12 Schools

GlobeNewswire
·
21 Jan

U.S. Weekly Review: Stock Market Rises On Tame Inflation, Bank Earnings

Investor’s Business Daily
·
18 Jan

Stock Track | ARS Pharmaceuticals Inc (SPRY) Soars 5.55% on Analyst Optimism

Stock Track
·
15 Jan

Analysts Are Bullish on These Healthcare Stocks: Kura Oncology (KURA), ARS Pharmaceuticals (SPRY)

TIPRANKS
·
15 Jan

ARS Pharmaceuticals Is Maintained at Strong Buy by Raymond James

Dow Jones
·
15 Jan